Metastatic bone disease

Metastatic bone disease is the most common malignancy of bone, it is estimated that 70% of all malignant bone tumors are metastatic in origin. At autopsy it has been reported between 30 to 85% of patients who die from cancer show occult skeletal metastases. Bone is the third most common site of met...

Full description

Bibliographic Details
Main Author: Errol U. Hutagalung
Format: Article
Language:English
Published: Faculty of Medicine Universitas Indonesia 2004-05-01
Series:Medical Journal of Indonesia
Online Access:http://mji.ui.ac.id/journal/index.php/mji/article/view/141
id doaj-e4cbb9b62d1b4f13ad9db9b6163534a8
record_format Article
spelling doaj-e4cbb9b62d1b4f13ad9db9b6163534a82020-11-25T01:30:49ZengFaculty of Medicine Universitas Indonesia Medical Journal of Indonesia0853-17732252-80832004-05-0113210.13181/mji.v13i2.141141Metastatic bone diseaseErrol U. Hutagalung Metastatic bone disease is the most common malignancy of bone, it is estimated that 70% of all malignant bone tumors are metastatic in origin. At autopsy it has been reported between 30 to 85% of patients who die from cancer show occult skeletal metastases. Bone is the third most common site of metastatic process after lung and liver. 80% of metastatic bone disease arise from Ca of breast, prostate, lung, kidney and thyroid. Typical location are thoracolumbal spine, pelvis, ribs, skull and proximal of femur and humerus. Pathogenesis of metastatic bone disease had been explained by Paget’s “Seed and Soil” theory and Ewing’s circulatory theory. Diagnostic procedures include complete laboratory examination, diagnostic bone imaging, chest x-ray, total body scan, CT-scan of chest, abdomen and pelvis and confirmed by histopathological examination. Management of metastatic bone disease is palliative that includes : chemotherapy, radiotherapy, bisphosphonates and surgical treatment for impending / established pathologic fracture to alleviate pain, ease nursing and restore functional activity. (Med J Indones 2004; 13: 127-31) Keywords: bone cancer, metastases http://mji.ui.ac.id/journal/index.php/mji/article/view/141
collection DOAJ
language English
format Article
sources DOAJ
author Errol U. Hutagalung
spellingShingle Errol U. Hutagalung
Metastatic bone disease
Medical Journal of Indonesia
author_facet Errol U. Hutagalung
author_sort Errol U. Hutagalung
title Metastatic bone disease
title_short Metastatic bone disease
title_full Metastatic bone disease
title_fullStr Metastatic bone disease
title_full_unstemmed Metastatic bone disease
title_sort metastatic bone disease
publisher Faculty of Medicine Universitas Indonesia
series Medical Journal of Indonesia
issn 0853-1773
2252-8083
publishDate 2004-05-01
description Metastatic bone disease is the most common malignancy of bone, it is estimated that 70% of all malignant bone tumors are metastatic in origin. At autopsy it has been reported between 30 to 85% of patients who die from cancer show occult skeletal metastases. Bone is the third most common site of metastatic process after lung and liver. 80% of metastatic bone disease arise from Ca of breast, prostate, lung, kidney and thyroid. Typical location are thoracolumbal spine, pelvis, ribs, skull and proximal of femur and humerus. Pathogenesis of metastatic bone disease had been explained by Paget’s “Seed and Soil” theory and Ewing’s circulatory theory. Diagnostic procedures include complete laboratory examination, diagnostic bone imaging, chest x-ray, total body scan, CT-scan of chest, abdomen and pelvis and confirmed by histopathological examination. Management of metastatic bone disease is palliative that includes : chemotherapy, radiotherapy, bisphosphonates and surgical treatment for impending / established pathologic fracture to alleviate pain, ease nursing and restore functional activity. (Med J Indones 2004; 13: 127-31) Keywords: bone cancer, metastases
url http://mji.ui.ac.id/journal/index.php/mji/article/view/141
work_keys_str_mv AT erroluhutagalung metastaticbonedisease
_version_ 1725089565536944128